Back to search

Ondine Biomedical Limited

10570442

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

BELFRY HOUSE CHAMPIONS WAY, LONDON, NW4 1PX
Incorporated 18/01/2017

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Ms Carolyn Mitchell Cross

director · Since 18/01/2017

DIRECTOR & EXECUTIVE OFFICER

CANADIAN · CANADA · Age 64

Persons with Significant Control

Ondine Biomedical Inc.

75–100% shares
75–100% votes
Appoint directors

888 - 1100, Melville Street, Vancouver

Reg: Bc0526736 · Bc Registries · Public Corporation

Notified 06/12/2021

Former PSCs

Ms Carolyn Mitchell Cross

Ceased 06/12/2021

CompanyRankvs 2697+ SIC 72110 peers
34

Financial strength13th percentile among SIC peers · 3/25
Employees47th percentile among SIC peers · 7/15
LiquidityNo balance sheet data · 0/20
Longevity9 years trading (max 15) · 9/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength3/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity9/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

-£31k

Balance sheet strength

Cash

£1k

Cash in the bank

Net Current Assets

Working capital

Current Assets

Current Liabilities

£32k

1avg. employees
Prepared with Digita Accounts Production Advanced

EstimatesDerived

YearImplied Profit
2024-£1k
2023-£1k
2022-£1k
2021-£1k
2020-£1k
2019-£10k

Derived from filed accounts. Not audited figures.